Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus DNA vaccine H1N1 - Vical

Next Previous
Drug Profile

Influenza A virus DNA vaccine H1N1 - Vical

Alternative Names: Influenza A (H1N1) DNA vaccine - Vical; Pandemic influenza plasmid DNA vaccine H1N1- Vical; Swine flu DNA vaccine - Vical; Vaxfectin®-formulated plasmid DNA vaccine H1N1 - Vical

Latest Information Update: 07 Mar 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Vical
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Influenza A virus H1N1 subtype

Most Recent Events

  • 07 Mar 2014 Influenza A virus DNA vaccine H1N1 - Vical is available for licensing as of 31 Dec 2011. http://www.vical.com
  • 31 Dec 2011 Suspended - Phase-I for Influenza-A virus H1N1 subtype in USA (IM)
  • 27 Apr 2011 Immunogenicity and adverse events data from a phase I trial in Influenza-A virus H1N1 subtype infections released by Vical
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top